RGEN - Repligen - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RGEN is currently covered by 10 analysts with an average price target of $167.28. This is a potential upside of $40.01 (-10.43%) from yesterday's end of day stock price of $186.75.

Repligen's activity chart (see below) currently has 154 price targets and 137 ratings on display. The stock rating distribution of RGEN is 16.67% HOLD and 83.33% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 67.16% with an average time for these price targets to be met of 109.43 days.

Highest price target for RGEN is $225, Lowest price target is $140, average price target is $167.28.

Most recent stock forecast was given by DAN LEONARD from UBS on 09-Sep-2026. First documented stock forecast 15-Apr-2014.

Currently out of the existing stock ratings of RGEN, 4 are a HOLD (16.67%), 20 are a BUY (83.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 25-Feb-2026

$225

$48.11 (27.20%)

$160

14 days ago
(09-Sep-2026)

1/4 (25%)

$59.95 (36.32%)

84

Buy Since 07-Oct-2025

$160

$-16.89 (-9.55%)

$140

2 months 17 days ago
(06-Jul-2026)

7/7 (100%)

$18.54 (13.11%)

122

Buy Since 01-Dec-2025

$150

$2.99 (2.03%)

$190

3 months 20 days ago
(03-Jun-2026)

0/2 (0%)

$28.27 (23.22%)

Buy Since 03-Aug-2023

$160

$12.99 (8.84%)

$204

4 months 8 days ago
(15-May-2026)

5/15 (33.33%)

$57.13 (55.54%)

97

Buy Since 24-Jun-2025

$160

$12.99 (8.84%)

$145

4 months 17 days ago
(06-May-2026)

3/7 (42.86%)

$34.24 (27.23%)

66

Show more analysts

Please expand the browser size to see the chart

What is RGEN (Repligen) average time for price targets to be met?

On average it took 109 days for the stock forecasts to be reached, with an average price target met ratio of 67.16%.

Which analyst most recently updated their price target on RGEN (Repligen)?

Dan Leonard

Which analyst has the most public recommendations on RGEN (Repligen)?

Dan Leonard works at UBS and has 23 price targets and 14 ratings on RGEN

Which analyst is the currently most bullish on RGEN (Repligen)?

Matt Hewitt with the highest potential upside of $79.9

Which analyst is the currently most reserved on RGEN (Repligen)?

Drew Jones with the lowest potential downside of -$65.1

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?